Literature DB >> 19339646

Low-density lipoprotein cholesterol reduction and prevention of cardiovascular disease.

Evan A Stein.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19339646      PMCID: PMC2665973          DOI: 10.1016/S0025-6196(11)60537-5

Source DB:  PubMed          Journal:  Mayo Clin Proc        ISSN: 0025-6196            Impact factor:   7.616


× No keyword cloud information.
  18 in total

1.  Clinical significance of statin pleiotropic effects: hypotheses versus evidence.

Authors:  Michael H Davidson
Journal:  Circulation       Date:  2005-05-10       Impact factor: 29.690

2.  Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins.

Authors:  C Baigent; A Keech; P M Kearney; L Blackwell; G Buck; C Pollicino; A Kirby; T Sourjina; R Peto; R Collins; R Simes
Journal:  Lancet       Date:  2005-09-27       Impact factor: 79.321

3.  Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group.

Authors:  S Hulley; D Grady; T Bush; C Furberg; D Herrington; B Riggs; E Vittinghoff
Journal:  JAMA       Date:  1998-08-19       Impact factor: 56.272

4.  Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)

Authors: 
Journal:  Lancet       Date:  1994-11-19       Impact factor: 79.321

Review 5.  Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines.

Authors:  Scott M Grundy; James I Cleeman; C Noel Bairey Merz; H Bryan Brewer; Luther T Clark; Donald B Hunninghake; Richard C Pasternak; Sidney C Smith; Neil J Stone
Journal:  Circulation       Date:  2004-07-13       Impact factor: 29.690

6.  Intensive versus moderate lipid lowering with statins after acute coronary syndromes.

Authors:  Christopher P Cannon; Eugene Braunwald; Carolyn H McCabe; Daniel J Rader; Jean L Rouleau; Rene Belder; Steven V Joyal; Karen A Hill; Marc A Pfeffer; Allan M Skene
Journal:  N Engl J Med       Date:  2004-03-08       Impact factor: 91.245

7.  The Lipid Research Clinics Coronary Primary Prevention Trial results. I. Reduction in incidence of coronary heart disease.

Authors: 
Journal:  JAMA       Date:  1984-01-20       Impact factor: 56.272

8.  Report of the National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. The Expert Panel.

Authors: 
Journal:  Arch Intern Med       Date:  1988-01

Review 9.  Intensive lowering of low-density lipoprotein cholesterol levels for primary prevention of coronary artery disease.

Authors:  Dean G Karalis
Journal:  Mayo Clin Proc       Date:  2009-04       Impact factor: 7.616

Review 10.  Impact of ezetimibe on atherosclerosis: is the jury still out?

Authors:  Firas J Al Badarin; Iftikhar J Kullo; Stephen L Kopecky; Randal J Thomas
Journal:  Mayo Clin Proc       Date:  2009-04       Impact factor: 7.616

View more
  2 in total

1.  Conflicts of interest, authorship, and disclosures in industry-related scientific publications: the tort bar and editorial oversight of medical journals.

Authors:  Laurence J Hirsch
Journal:  Mayo Clin Proc       Date:  2009-09       Impact factor: 7.616

2.  Risk Factors Associated with Failure to Achieve the Low Density Lipoprotein Cholesterol Therapeutic Target in Patients with Acute Coronary Syndrome: A Longitudinal, Single Centre Investigation.

Authors:  Mojgan Hajahmadi Pourrafsanjani; Ebrahim Khayati Shal; Sina Khezrpour
Journal:  High Blood Press Cardiovasc Prev       Date:  2019-01-25
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.